Veeva Systems unveils new app MyVeeva for clinical research sites
Category: #health  By Pankaj Singh  Date: 2020-05-21
  • share
  • Twitter
  • Facebook
  • LinkedIn

Veeva Systems unveils new app MyVeeva for clinical research sites

Veeva Systems, a renowned leader in cloud-based software for the global life sciences industry, has reportedly unveiled a new application for clinical research sites. With competencies for patient adherence, eSource, eConsent, ePRO, virtual visits as well as an easy to use portal for patients.

The new application, MyVeeva, also makes it easy for the clinical research sites to bring a paperless clinical trial and patient-centric experience for sponsors and patients. The new application is free for clinical research sites and also integrates effortlessly with the Veeva SiteVault.

Jessica Collins, program director, investigator-initiated clinical trials, Vanderbilt University Medical Center, stated that there is a crucial need for clinical solutions that would decrease the load on patients taking part in clinical trials and would also make study implementation simpler for sites.

Collins further stated that having the capability to perform parts of a clinical study remotely is critical to a superior patient experience and a fast-moving study conduct.

The new application empowers clinical research coordinators, doctors, and patients to cooperate remotely through advanced audio & video abilities, thereby decreasing the need for face to face visits. Clinical researchers could collect as well as record the patient data by electronic means, this further makes it easy for patients to report on treatment results.

The researchers could share information electronically with ease and could also get the patient permission. It could also help the patients in taking medicines and stick to their treatment schedules as well.

Henry Levy, GM of Vault CDMS, site, and patient solutions, Veeva, stated that the COVID-19 pandemic generated a greater urgency for clinical trials to be more virtual and to bring in safe and an appropriate patient experience.

The sites would have the freedom to utilize the new application with Veeva Vault Clinical and Veeva SiteVault applications along with third-party clinical applications as well. The app would be released and made accessible from December 2020.

Source credit: https://www.businesswire.com/news/home/20200519005365/en/Veeva-Announces-MyVeeva-Enable-Patient-Centric-Clinical-Trials



About Author

Pankaj Singh

Email: [email protected]   

Pankaj Singh

Pankaj Singh Develops content for Market Size Forecasters, Algosonline, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

More News By Pankaj Singh

WHO halts Hydroxychloroquine clinical trial over safety concerns
WHO halts Hydroxychloroquine clinical trial over safety concerns
By Pankaj Singh

The malaria drug Hydroxychloroquine has been in the headlines for the past few months. The drug was hailed as the game-changer in the treatment of COVID-19 by the Trump administration. However, the WHO (World Health Or...

BPCL launches WhatsApp initiative to facilitate domestic gas booking
BPCL launches WhatsApp initiative to facilitate domestic gas booking
By Pankaj Singh

  • BPCL has launched a domestic gas booking facility through WhatsApp
     
  • “Bharat Gas” cylinders can be booked through a Smartli...

Poxel announces preclinical outcomes on PXL770 for NASH Combinations
Poxel announces preclinical outcomes on PXL770 for NASH Combinations
By Pankaj Singh

Poxel SA, the France-based dynamic biopharmaceutical firm developing advanced drugs for metabolic diseases, has reportedly announced the preclinical outcomes for PXL770, the main molecule in its AMPK (adenosine monopho...